HomeNewsEpsilon Readies To Boost Cannabis Medicine Output

Epsilon Readies To Boost Cannabis Medicine Output

The medical cannabis company formerly known as THC Global has been busy getting new equipment in place for its Southport facility.

Epsilon Healthcare Limited (ASX:EPN), formerly THC Global Group Limited, commenced trading under the ASX Code EPN in late February this year. The change of name occurred to better reflect  the company’s current approach as a healthcare and pharmaceuticals business.

In its Q1 2021 quarterly update released last week, Epsilon said it had completed the installation of more new equipment at its facility in Southport, Queensland. Among it was a conveyor system for the filling and torquing of cannabis oil bottles. Following a Therapeutic Goods Administration inspection, the equipment was expected to commence operating “within the next week”, so is likely already operating.

The Southport facility is also progressing its ability to offer primary and secondary packaging of dried flower, and the equipment needed to do so has been secured.

Epsilon Healthcare says its Southport Facility is one of the largest pharmaceutical GMP cannabis manufacturing facilities in the world.

With regard to its clinic business Tetra Health, the first quarter of this year saw record numbers of initial patient consultations and its highest monthly revenue in March. Tetra Health, which was previously only operating on a telehealth basis, also opened its first in-person clinic in March. The company intends opening other in-person clinics in New South Wales, Queensland, and Victoria this year.

“I am pleased to report the success of the initiatives which were implemented throughout the last quarter of 2020 that are now scaling the offering of the Epsilon Group of Companies to be seen as a true market participant in the Global Medicinal Cannabis landscape,” said Epsilon Group CEO Jarrod White.

Also released last week was the company’s Consolidated Financial Report for the Year Ended 31 December 2020.

The report notes trading revenue for 2020 reached $6.95 million – 45% year-on-year growth on  2019 audited revenue. Its hydroponics equipment sales in Canada saw 25% year-on-year growth. The first sales of medicinal cannabis products also occurred last year, resulting in $1.07m in sales for the six months to 31 December 2020.

As for Tetra Health, which was acquired in May 2020 while still under the THC Global banner,  it generated $563k in sales on the 7-months to 31 December 2020.

Steven Gothrinet
Steven Gothrinet has been part of the Hemp Gazette in-house reporting team since 2015. Steven's broad interest in cannabis was initially fueled by the realisation of industrial hemp's versatility across multiple sectors. You can contact Steve here.

Most Popular